In triple-negative breast cancer (TNBC), where PD-1/PD-L1 immunotherapy often proves ineffective, recent research has uncovered a novel mechanism by which core fucosylation of B7-H3 at its N-glycans facilitates immune escape. The gene discussed is CD274; the disease is triple-negative breast carcinoma.